CD4 and viral infectious disease: Future research should aim to assess the magnitude and the durability of SARS-CoV-2 vaccine-induced antibody and T cell responses in PLWH with particular focus on those with uncontrolled viral infection and/or who have low CD4+ T cell counts to inform the best strategy for boosting.